Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.720
+0.020 (0.43%)
At close: Apr 9, 2026, 4:00 PM EDT
4.570
-0.150 (-3.18%)
After-hours: Apr 9, 2026, 4:21 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $24.96 million as of April 9, 2026. Its market cap has increased by 163.07% in one year.
Market Cap
24.96M
Enterprise Value
2.93M
1-Year Change
163.07%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $24.96M, an increase of 131.35%. That is a compound annual growth rate of 91.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 25.34M | 21.44% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 25.62M |
| Lixte Biotechnology Holdings | 25.09M |
| Skye Bioscience | 23.85M |
| Marker Therapeutics | 23.51M |
| Barinthus Biotherapeutics | 23.23M |
| AEON Biopharma | 23.03M |
| Plus Therapeutics | 22.85M |
| Tempest Therapeutics | 22.81M |